News coverage about Castlight Health (NYSE:CSLT) has trended somewhat positive on Tuesday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Castlight Health earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave press coverage about the software maker an impact score of 45.7186079586247 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
These are some of the media headlines that may have effected Accern Sentiment’s scoring:
- Market Trends Toward New Normal in Castlight Health, inc, Marriot Vacations Worldwide, AnaptysBio, Compass Diversified, Triumph, and Asbury Automotive Group — Emerging Consolidated Expectations, Analy (markets.financialcontent.com)
- Brokerages Anticipate Castlight Health (CSLT) Will Announce Quarterly Sales of $36.67 Million (americanbankingnews.com)
- John C. Doyle Sells 21,160 Shares of Castlight Health (CSLT) Stock (americanbankingnews.com)
- Mangini Siobhan Nolan Sells 14,430 Shares of Castlight Health (CSLT) Stock (americanbankingnews.com)
- -$0.06 Earnings Per Share Expected for Castlight Health (CSLT) This Quarter (americanbankingnews.com)
A number of research firms have recently weighed in on CSLT. Chardan Capital restated a “buy” rating and issued a $5.75 price target (down from $6.30) on shares of Castlight Health in a report on Thursday, February 22nd. Zacks Investment Research upgraded shares of Castlight Health from a “hold” rating to a “buy” rating and set a $3.75 price target on the stock in a report on Wednesday, January 31st. Cantor Fitzgerald upgraded shares of Castlight Health from a “neutral” rating to an “overweight” rating and set a $5.00 price target on the stock in a report on Tuesday, January 30th. Finally, ValuEngine upgraded shares of Castlight Health from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $5.25.
CSLT stock traded down $0.08 during trading on Tuesday, reaching $3.52. The company had a trading volume of 6,419 shares, compared to its average volume of 392,814. The stock has a market capitalization of $483.02 million, a PE ratio of -13.54 and a beta of 1.38. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.02. Castlight Health has a twelve month low of $3.15 and a twelve month high of $4.75.
Castlight Health (NYSE:CSLT) last released its earnings results on Wednesday, February 21st. The software maker reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.01. The company had revenue of $37.00 million during the quarter, compared to analysts’ expectations of $36.36 million. Castlight Health had a negative net margin of 39.39% and a negative return on equity of 25.09%. Castlight Health’s revenue for the quarter was up 23.7% on a year-over-year basis. During the same period last year, the business earned ($0.01) EPS. equities research analysts expect that Castlight Health will post -0.32 earnings per share for the current year.
In other Castlight Health news, CFO Mangini Siobhan Nolan sold 14,430 shares of the firm’s stock in a transaction that occurred on Thursday, May 17th. The shares were sold at an average price of $3.80, for a total transaction of $54,834.00. Following the completion of the transaction, the chief financial officer now directly owns 121,413 shares of the company’s stock, valued at approximately $461,369.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John C. Doyle sold 21,160 shares of the firm’s stock in a transaction that occurred on Thursday, May 17th. The stock was sold at an average price of $3.79, for a total transaction of $80,196.40. Following the transaction, the chief executive officer now directly owns 165,672 shares of the company’s stock, valued at $627,896.88. The disclosure for this sale can be found here. Insiders sold a total of 36,140 shares of company stock valued at $137,120 over the last quarter. 22.58% of the stock is owned by company insiders.
About Castlight Health
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers communication and testing, implementation, and user customer support services.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.